Future research is necessary to confirm these findings in other AD cohorts, clarify whether the cumulative effect of these expression patterns is protective in vivo and by which sirt1-mediated mechanism, and determine whether augmentation of cell survival pathways such as sirt1 represents a viable strategy to delay neurodegeneration in prodromal AD. This evidence concerns the gene SIRT1 and Alzheimer disease.